Nothing Special   »   [go: up one dir, main page]

GB0815315D0 - Organ protection - Google Patents

Organ protection

Info

Publication number
GB0815315D0
GB0815315D0 GBGB0815315.7A GB0815315A GB0815315D0 GB 0815315 D0 GB0815315 D0 GB 0815315D0 GB 0815315 A GB0815315 A GB 0815315A GB 0815315 D0 GB0815315 D0 GB 0815315D0
Authority
GB
United Kingdom
Prior art keywords
organ protection
organ
protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0815315.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Priority to GBGB0815315.7A priority Critical patent/GB0815315D0/en
Publication of GB0815315D0 publication Critical patent/GB0815315D0/en
Priority to PCT/GB2009/002039 priority patent/WO2010020786A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0815315.7A 2008-08-21 2008-08-21 Organ protection Ceased GB0815315D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0815315.7A GB0815315D0 (en) 2008-08-21 2008-08-21 Organ protection
PCT/GB2009/002039 WO2010020786A1 (en) 2008-08-21 2009-08-20 Organ protection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0815315.7A GB0815315D0 (en) 2008-08-21 2008-08-21 Organ protection

Publications (1)

Publication Number Publication Date
GB0815315D0 true GB0815315D0 (en) 2008-09-24

Family

ID=39812412

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0815315.7A Ceased GB0815315D0 (en) 2008-08-21 2008-08-21 Organ protection

Country Status (2)

Country Link
GB (1) GB0815315D0 (en)
WO (1) WO2010020786A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2619216A4 (en) 2010-09-22 2014-04-02 Alios Biopharma Inc Substituted nucleotide analogs
CA2819041A1 (en) 2010-12-22 2012-06-28 Alios Biopharma, Inc. Cyclic nucleotide analogs
US8980865B2 (en) 2011-12-22 2015-03-17 Alios Biopharma, Inc. Substituted nucleotide analogs
SI2794627T1 (en) 2011-12-22 2019-02-28 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
EP2828277A1 (en) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3773148B2 (en) * 1997-10-29 2006-05-10 キッコーマン株式会社 Ischemic disease prevention, treatment and organ preservative
AU2003280117B2 (en) * 2002-11-20 2009-09-10 Newron Sweden Ab Compounds and methods for increasing neurogenesis
JP2008531631A (en) * 2005-03-03 2008-08-14 アンスティテュ ナシオナル ド ラ サント エ ド ラ ルシュルシェ メディカル（アンセルム） Use of EPAC antagonists to treat human cardiac hypertrophy

Also Published As

Publication number Publication date
WO2010020786A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
PL2918172T3 (en) Połączenia środków kontroli biologicznej i fungicydów
EP2280616A4 (en) Babybody
GB2465182B (en) Protective shelter
EP2257170A4 (en) Tetrahydrofuropyridones
EP2285758A4 (en) Fertilizer-pesticide throw-pack
EP2313147A4 (en) Morselizer
GB0815315D0 (en) Organ protection
EP2233305A4 (en) Printer-plotter
EP2285375A4 (en) Spiroazaindoles
GB0801589D0 (en) Mollusicide
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
AU3972P (en) Tobruk xTriticosecale
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium
AU3935P (en) DPV308 Dianella prunina
HU0700742D0 (en) Holograpmic quantum-copy protection
GB0715782D0 (en) Rutguard protection
GB0814118D0 (en) Property tycoon
GB0808644D0 (en) Places
GB0805336D0 (en) C m x
GB0809820D0 (en) Modified tissues
GB0811938D0 (en) Pintagram or Drinkagram
IL192531A0 (en) Watch-bluetooth combination
GB0810552D0 (en) Combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)